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Abstract
Background: In recent years a number of algorithms for cardiovascular risk assessment has been
proposed to the medical community. These algorithms consider a number of variables and express
their results as the percentage risk of developing a major fatal or non-fatal cardiovascular event in
the following 10 to 20 years
Discussion: The author has identified three major pitfalls of these algorithms, linked to the
limitation of the classical statistical approach in dealing with this kind of non linear and complex
information. The pitfalls are the inability to capture the disease complexity, the inability to capture
process dynamics, and the wide confidence interval of individual risk assessment.
Artificial Intelligence tools can provide potential advantage in trying to overcome these limitations.
The theoretical background and some application examples related to artificial neural networks and
fuzzy logic have been reviewed and discussed.
Summary: The use of predictive algorithms to assess individual absolute risk of cardiovascular
future events is currently hampered by methodological and mathematical flaws. The use of newer
approaches, such as fuzzy logic and artificial neural networks, linked to artificial intelligence, seems
to better address both the challenge of increasing complexity resulting from a correlation between
predisposing factors, data on the occurrence of cardiovascular events, and the prediction of future
events on an individual level.
Background
In the past few years a number of algorithms for cardio-
vascular risk assessment has been proposed to the medical
community [1-6]. Their purpose is to assist physicians in
defining the risk level of an individual patient with regard
to developing major cardiovascular events in the follow-
ing years.
These algorithms have been drawn from statistical analy-
ses performed on longitudinal study cohorts. These anal-
yses have taken into account events occurring in general
populations undergoing adequate follow-up for a suffi-
cient length of time. These algorithms consider a number
of variables and express their results as the percentage risk
of developing a major fatal or non-fatal cardiovascular
event in the following 10 to 20 years. For example, if the
algorithm gives origin to a 10% value, it means that 10 out
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of100 subjects in the reference population at a given time
with characteristics similar to those of the subject under
evaluation, would develop a cardiovascular event in the
following 10 years. These algorithms present some pitfalls
linked to the limitations of the classical statistical
approach in dealing with this kind of non linear and com-
plex information. The author has identified three. The aim
of this paper is to discuss the potential advantage pro-
vided by artificial intelligence tools in this specific setting.
Discussion
First pitfall: inability to capture disease complexity
The algorithms currently used employ a limited number
of variables. This is due to the fact that traditional statisti-
cal approaches tend to select only variables which have a
high level of linear correlation with the outcome variable.
Classical multivariable statistical techniques are based on
a statistical approach, by which only one factor at a time
is varied, and the other factors are held constant. With
these techniques, a given set of potential predictors with
respect to individual patients is difficult to interpret. This
is due to the limitations imposed by the underlying non-
linear links and the complex interactions between the fac-
tors under study.
Artificial neural networks (ANNs) are adaptive models for
data analysis particularly suitable for handling nonlinear
functions. The Multi-layer perceptron (MLP) is the most
widely used type of neural network. It is simple and based
on solid mathematical grounds. Input quantities are proc-
essed through successive layers of "neurons". There is
always an input layer, with a number of neurons equal to
the number of variables of the problem, and an output
layer, where the perceptron response is made available,
with a number of neurons equal to the desired number of
quantities computed from the inputs (very often only
one). The layers in between are called "hidden" layers in
which there are activation functions like logistic sigmoid
or hyperbolic tangent. This helps MLP networks to model
nonlinear mappings both strongly and mildly. The prob-
abilistic neural networks (PNN) constitute another kind
of general classification system, based on the Bayes the-
ory. These networks provide a general solution to pattern
classification problems by taking into account the relative
likelihood of events and use a priori information to
improve prediction. Like MPL, PNN use a supervised
training set to develop distribution functions within a pat-
tern layer. These functions, in the recall mode, are used to
estimate the likelihood of an input feature vector being
part of a learned category, or class. The learned patterns
can also be combined, or weighted, with the a priori prob-
ability, also called the relative frequency, of each category
to determine the most likely class for a given input vector.
ANNs are able to simultaneously handle a very high
number of variables notwithstanding the fact that these
are not linearly connected. This represents a tremendous
advantage in comparison with classical statistical models
when the quantity of available information has enor-
mously increased and non linearity dominates. With
ANNs one is more concerned about the actual number of
variables than about their nature. Due to their particular
mathematical infrastructure, ANNs have no limits in han-
dling increasing amounts of variables which constitute
the basis for developing recursive algorithms. ANNs can
input multiple factor values simultaneously, combining
and recombining them in different ways according to spe-
cific equations, which are generally non linear. In terms of
predictive values and of the number of predictive models,
the difference can be explained by the fact that conven-
tional statistics only reveal parameters which are signifi-
cant for the entire population, whereas artificial neural
networks include parameters which might not be signifi-
Table 1: Examples of artificial neural networks analyses in the cardiovascular field.
Year No. Pts Disease Variables Results
Diagnosis
Selker 1995 3453 Ischemia Clinical indicators ANN superior vs 
LogR
Ellenius et al 1997 88 MI Biochemical variables ANNs give added 
value
Baxt et al 2002 2204 MI History, clinical, 
biochemical EGC
High sensitivity (95%) 
and specificity (96%)
Prognosis
Baldassarre et al 2004 949 CV event biochemical, carotid 
US clinical indicators
ANN superior vs 
LDA
Voss et al 2002 5159 CV event Clinical, biochemical 
indicators
ANN superior vs 
LogR
Bigi et al 2005 496 Outcome after MI Clinical, exercise ECG 
and stress echo
ANN superior vs 
LDA
MI: Miocardial infarction; CV: cardiovascular; ANN Artificial neural networks; LogR: logistic regression; LDA: linear discriminant analysisBMC Cardiovascular Disorders 2006, 6:20 http://www.biomedcentral.com/1471-2261/6/20
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cant for the entire population, but which are highly signif-
icant on an individual level. Recently, studies on the use
of ANNs in the cardiovascular field have been published
(table 1). In all of these studies ANNs provided a better
predictive accuracy than did traditional statistical tech-
niques. There are two papers in particular that have
focused on the prediction of cardiovascular events in con-
junction with traditional risk factors in the general popu-
lation.
In the Baldassarre study, a database of 949 patients and 54
variables was analyzed to evaluate the capacity of ANNs to
recognize patients with a history of vascular events (VE+,
n = 196) or without a history of vascular events (VE-, n =
753), on the basis of vascular risk factors (VRFs), carotid
ultrasound variables (UVs) or both. The performance of
ANNs was assessed by calculating the percentage of cor-
rect identifications of VE+ and VE- patients (sensitivity
and specificity, respectively) and the predictive accuracy
(weighted mean between sensitivity and specificity).
Results showed that ANNs can be developed to identify
VE+ and VE- subjects more accurately than discriminant
analyses. When VRFs and UVs were used as input varia-
bles, ANNs provided better predictive capacity, with an
accuracy of 80.8% and 79.2%, respectively. The addition
of gender, age, weight, height and body mass index (BMI)
increased accuracy of prediction to 83.0%. When ANNs
were allowed to choose relevant input data automatically
(I.S. system-Semeion), 37 out of 54 variables were
selected, five of which were UVs. Using this set of variables
as input data, the performance of ANNs in their classifica-
tion task of VE+ patients reached a predictive accuracy of
85.0% and of 92.0%.
In the Voss study, the authors researched to determine
whether neural networks improved Logisitic Regression
(LR) risk assessment. The authors analyzed data from the
Prospective Cardiovascular Munster Study (PROCAM), a
large prospective epidemiological study on risk factors of
coronary heart disease among working men and women
in northern Germany. To estimate the risk of myocardial
infarction or death caused by an acute coronary event
(coronary events) during a 10 year follow-up among 5159
men aged 35–65 years at recruitment into PROCAM, a
multi-layer perceptron (MLP) and probabilistic neural
networks (PNN) were employed. Overall, 325 coronary
events occurred in this group. The performance of each
procedure was assessed by measuring the area under the
Theoretical distribution of outputs of 1600 different neural networks predicting "plausibility" of event occurrence Figure 1
Theoretical distribution of outputs of 1600 different neural networks predicting "plausibility" of event occurrence.BMC Cardiovascular Disorders 2006, 6:20 http://www.biomedcentral.com/1471-2261/6/20
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receiver-operating characteristics curve (AUROC). The
AUROC of the MLP was greater than that of the PNN
(0.897 versus 0.872), and both exceeded the AUROC by
an LR of 0.840. This analysis suggests that using the MLP
to identify high-risk individuals candidates for drug treat-
ment would allow prevention of 25% of coronary events
in middle-aged men, compared to 15% with LR and 11%
with the PNN.
Second pitfall: inability to capture process dynamics
A major drawback of the probabilistic approach is that
prediction tends to behave as a static process. If a given
subject has an absolute risk of 62%, it means that there is
a 62% probability that he/she will suffer from a major car-
diovascular event in the following 10 years, and a 38%
probability that he/she will not. The lottery of probability
will tell us the truth in the future. In this situation the sub-
ject is in a static position in one out of two mutually
excluding possibilities: event or non event. There is no
possibility to make any sort of inference about a specific
risk trend, despite the fact that the same sort of assessment
performed 10 years before resulted in an absolute risk of
34%. In fact, even if after 10 years the algorithm shows
that there are more probabilities that the subject will suf-
fer from an event, the imposition of binary logic does not
allow the mathematical figuring out of a formal and
dynamic progression of the risk. The subject will still
remain uncertain and apparently his/her fate will still
depend on chance. The use of fuzzy logic with artificial
intelligence, and the consequent use of a "plausibility"
rather than a probability concept, can help overcoming
this subtle trap.
Readers might refer to the previous paper to review the
difference between probability and plausibility [7] and to
a series of papers by Drs. Helgason and Jobe, addressing
the issues of complexity and "n" of 1 concept [8-11].
The physician would be paradoxically more precise with
fuzzy terminology: he/she could explain to the patient
that, given his/her present clinical condition, he/she has
reached 62% of the course between a previous safe condi-
tion and a future unavoidable event, as a person would
explain to one that without noticing it, one is walking
from a safe point to the edge of a cliff. This concept intro-
duces a dynamic process. In fact, since in the example the
plausibility of an event was 34%, the patient is now told
that he/she has very much progressed along a virtual path,
and that if nothing will be done to slow this evolution
down, there are reasons to think that in another 10 years'
time he/she will be very close to a point where an
unwanted event will be almost unavoidable (90%). This
would make a great difference for the subject, who would
not feel part of a cruel lottery anymore, but substantially
aware that his/her destiny is already written if nothing will
change as to his/her risk factors.
As stated in a previous article [7], in order to deal with a
certain degree of uncertainty the use of fuzzy logic would
allow the escape from the trap of the probability theory
and the advantage of making certain prognoses easier for
the patient to understand.
Readers might find an interesting review of the literature
regarding medicine and the use of fuzzy logic by Drs.
Nieto and Torres [12].
Third pitfall: wide confidence interval of individual risk 
assessment
A major unavoidable pitfall of the translation of group
statistics onto an individual level is linked to the problem
of the wide confidence interval of classifications. Within
classical statistical approaches the individual is assimi-
lated into a subgroup of individuals who have, on aver-
age, a given probability of an event.
We know that any kind of statistical inference unfortu-
nately is extremely weak in the absence of a "sample",
which by definition requires a number >1. For this reason,
predictive models can dramatically fail when applied to
the single individual.
In a model that has an overall 90% accuracy in predicting
an event on a group level, the degree of confidence can
drop substantially when applied to a single subject.
Suppose that a predictive model for risk assessment in
study data has been developed and validated and that it
allows an overall accuracy of 0.9. Suppose that the confi-
dence interval of this predictive rate is 0.06 (0.84–0.96).
The first step is to assess a group of new subjects with our
tools. We can reasonably expect to make classification
mistakes within a range of 4%–16%. Therefore, 4–16 out
of 100 new patients would be incorrectly assessed with
regard to their absolute risk.
If a new patient has been classified as in high risk to suffer
from myocardial infarction in the next 10 years, the
patient might think that there is a 90% chance that he/she
has been correctly classified (84% at worst and 96% at
best).
Unfortunately the patient's confidence interval in this
classification would not be equal to that of the group,
since in case of misclassification the patient would suffer
from an all or nothing situation (correct prognosis vs
incorrect prognosis). This would mean a 100% difference.BMC Cardiovascular Disorders 2006, 6:20 http://www.biomedcentral.com/1471-2261/6/20
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In other words, on single subject level the confidence
interval would be wider than the mean accuracy rate at a
group level.
Is there any solution to this problem?
Since it is not possible to turn a single individual into a
group of individuals on which to perform some statistics,
one could do the opposite: treat a single individual with a
group of statistics. This means using several independent
classification models on the same individual. These mod-
els make different errors in order to obtain a similar aver-
age predictive capacity. Artificial neural networks allow
this.
Neural networks can input multiple factor values simulta-
neously, combining and recombining them in different
ways according to specific equations which are generally
non linear. Compared with classic statistics in assessing
cardiovascular risk [13-15] and in addition to their
increased power as modelling techniques, neural net-
works allow for the building up of a high number of inde-
pendent models which, have different predictive capacity
in classifying patients according to certain targets, due to
slight differences in their architecture, topology and learn-
ing laws. Overall, neural networks belonging to specific
settings do not provide a unique solution, because their
performance is determined by several factors, such as the
initial randomized incidence of interconnections between
nodes, the order of presentation of cases during the train-
ing cycle and the number of training cycles. Other varia-
bles pertaining to the mathematical attributes of a specific
neural network will also affect the final state of a trained
neural network, allowing for a very high number of differ-
ent possible combinations. Evolutionary algorithms have
in fact been proposed to find the most suitable design of
neural networks, in order to allow a better prediction,
given the high number of possible combinations of
parameters[16]. In theory, therefore, it is possible to train
many different neural networks with the same set of data,
with a resulting sizeable assembly of artificial neural net-
works that have a similar average performance but a dif-
ferent predisposition to make mistakes on an individual
level. This way it is possible to produce a large set of neu-
ral networks with high training variability able to inde-
pendently process a set of new patients and to predict
their survival plausibility. Up to a thousand answers
would be generated for each patient. Therefore when a
new patient has to be classified, thanks to this sort of par-
liament of independent judges acting simultaneously, a
specific distribution of output values could be obtained
with a resulting descriptive statistics (mean, median, vari-
ance, confidence interval, etc.). It is interesting to note
that the classification output of neural networks is gener-
ally expressed according to the fuzzy logic scheme, along
a continuous scale of "degree of membership" to the tar-
get class, ranging from 0 (minimum degree of member-
ship) to 1 (maximum degree of membership). According
to the above reasoning it could be possible to establish a
degree of confidence of a specific classification suitable for
the individual patient. It could also be possible to over-
come the dogma by which the possibility to make a statis-
tical inference when a sample is composed by just one
subject is excluded.
Summary
The use of predictive algorithms to assess individual abso-
lute risk of future cardiovascular events is currently ham-
pered by methodological and mathematical flaws. The use
of newer approaches, such as fuzzy logic and artificial
neural networks, linked to artificial intelligence seems to
better address both the challenge of the increasing com-
plexity of predisposing factors linked to the occurrence of
cardiovascular events data and the prediction of future
events on an individual level.
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